Northstar Ventures has invested £250,000 via the North East Spinout Inspire Fund in Gnosis Health, to support the development and launch of AI-powered digital healthcare assistant MAXine, designed to transform the management of Parkinson’s disease.

The investment forms part of a £570,000 seed round alongside £320,000 from SFC Capital, leveraging a £550,000 Innovate UK investor partnership grant, bringing total funding to £1.1m.

Gnosis Health is a spinout of the universities of Newcastle and Plymouth. Its MAXine healthcare assistant matches a patient-centric solution to an urgent clinical need.

Integrating data from wearables, patient reported outcomes and behavioural patterns, MAXine provides real time insights to patients and clinicians. It offers continuous, adaptive monitoring that enhances self-management and improves care team communication.

The platform has demonstrated strong patient engagement in pilot studies, plus a potential 25% reduction in patient care costs.